Perfect Day Acquires Sterling Biotech Ltd

Perfect Day Inc. announces the Food Safety and Standards Authority of India has approved the company’s application for its animal-free milk proteins, opening the door for commercialization in India. In the near-term, Perfect Day will export animal-free protein produced in India to meet increasing global customer demands while it works on building a roadmap for domestic commercial opportunities.

The company also completed its acquisition of Sterling Biotech Ltd (SBL), advancing the company’s manufacturing capacity and owned manufacturing network. This acquisition will double the company’s production capability in the near-term with the addition of four high-value assets. These manufacturing facilities include robust precision fermentation capabilities with existing fermenters that will allow the company to expand its precision fermentation capabilities in the months ahead while continuing to service existing SBL customers in both the pharma and protein sectors.

“We’re scaling our impact to all corners of the world. Expanding our commercialization and manufacturing capabilities in India is a critical step forward,” said Narayan TM, Perfect Day’s president. “Through regulatory approval and the acquisition of these state-of-the-art facilities in India, we’ve grown our presence in this important market, extending our ability to meet increasing global demand and deliver even more products to consumers.”   

The facilities also are outfitted for other premium, pharmaceutical-grade ingredient production, including gelatin and dicalcium phosphate. This marks another chapter in Perfect Day’s mission as it expands its technology capabilities, ingredient innovation, and planet positive impact beyond animal-free milk proteins.

“This strategic acquisition stands to vastly expand our ability to make and sell protein while leveraging our robust technology platform across new ingredient opportunities,” said Ryan Pandya, CEO and co-founder of Perfect Day. “Our mission is one driven by collaboration, and we look forward to working closely with Sterling Biotech’s existing customers and employees as we continue to expand our investment in India and drive positive change together.”